We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Universal Health's (UHS) Q1 Earnings: What is in Store?
Read MoreHide Full Article
Universal Health Services, Inc. (UHS - Free Report) is set to report first-quarter 2020 results on Apr 27, after market close.
For the to-be-reported quarter, the Zacks Consensus Estimate for earnings is pegged at $2.64, indicating a 7.8% increase from the year-ago reported figure.
Let’s see how things are shaping up for this announcement.
In the quarter to be reported, the company’s performance is likely to have been driven by its consistently well-performing segments, namely Acute Care and Behavioral Health. Both segments have been contributing to the top line over the last several quarters.
The consensus mark for net revenues at Acute Care and Behavioral Health suggests a 6.7% and 4% improvement from the respective prior-year reported numbers.
The Zacks Consensus Estimate for total revenues stands at $2.9 billion, implying growth of 3.9% from the year-earlier reported figure.
Licensed beds at both hospitals are likely to have increased, continuing with its trend since 2012. The consensus mark for average licensed beds at Behavorial Health segment suggests a rise of 0.8% while the same for acute care (U.S. and Puerto Rico) indicates an increase of 0.4%.
Universal Health is likely to have continued focusing on its behavioral health joint venture portfolio.
However, the company’s revenues might have suffered at the end of the quarter due to the coronavirus effect. The cancellation of elective surgeries in order to accommodate coronavirus patients in greater numbers might have hurt its top line to some extent.
Also, the company is anticipated to have incurred escalating expenses due to higher salaries, wages and benefits plus other operating expenses, which in turn, might have weighed on the margins.
What the Quantitative Model States
Our proven model does not conclusively predict an earnings beat for Universal Health this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise, which is not the case here. You can seethe complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: Universal Health has an Earnings ESP of -13.39%. This is because its Most Accurate Estimate is pegged at $2.29, lower than the Zacks Consensus Estimate of $2.64. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Universal Health Services, Inc. Price and EPS Surprise
Zacks Rank: Universal Health carries a Zacks Rank #3, which increases the predictive power of ESP. However, its -13.59% ESP leaves surprise prediction difficult for the stock this time around.
Q4 Highlights and Surprise History
Universal Health’s fourth-quarter 2019 adjusted earnings of $2.79 per share beat the Zacks Consensus Estimate by 6.9%. Moreover, the bottom line increased 17.7% year over year on the back of higher revenues.
The company managed to beat on earnings in two of the trailing four quarters, missing the same in the other two. The average trailing four-quarter positive surprise is 0.01%.
Stocks to Consider
Some stocks worth considering from the medical sector with the perfect mix of elements to surpass estimates in the next releases are as follows:
Centene Corporation (CNC - Free Report) has an Earnings ESP of +21.25% and a Zacks Rank #2. The company is scheduled to release first-quarter earnings on Apr 28.
Anthem, Inc. is slated to announce first-quarter earnings on Apr 29. The stock has an Earnings ESP of +1.28% and a Zacks Rank of 3.
MEDNAX, Inc. (MD - Free Report) is set to report first-quarter earnings on May 7. The stock is #2 Ranked and has an Earnings ESP of +4.15%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. Today, See These 5 Potential Home Runs >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Universal Health's (UHS) Q1 Earnings: What is in Store?
Universal Health Services, Inc. (UHS - Free Report) is set to report first-quarter 2020 results on Apr 27, after market close.
For the to-be-reported quarter, the Zacks Consensus Estimate for earnings is pegged at $2.64, indicating a 7.8% increase from the year-ago reported figure.
Let’s see how things are shaping up for this announcement.
In the quarter to be reported, the company’s performance is likely to have been driven by its consistently well-performing segments, namely Acute Care and Behavioral Health. Both segments have been contributing to the top line over the last several quarters.
The consensus mark for net revenues at Acute Care and Behavioral Health suggests a 6.7% and 4% improvement from the respective prior-year reported numbers.
The Zacks Consensus Estimate for total revenues stands at $2.9 billion, implying growth of 3.9% from the year-earlier reported figure.
Licensed beds at both hospitals are likely to have increased, continuing with its trend since 2012. The consensus mark for average licensed beds at Behavorial Health segment suggests a rise of 0.8% while the same for acute care (U.S. and Puerto Rico) indicates an increase of 0.4%.
Universal Health is likely to have continued focusing on its behavioral health joint venture portfolio.
However, the company’s revenues might have suffered at the end of the quarter due to the coronavirus effect. The cancellation of elective surgeries in order to accommodate coronavirus patients in greater numbers might have hurt its top line to some extent.
Also, the company is anticipated to have incurred escalating expenses due to higher salaries, wages and benefits plus other operating expenses, which in turn, might have weighed on the margins.
What the Quantitative Model States
Our proven model does not conclusively predict an earnings beat for Universal Health this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise, which is not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.
Earnings ESP: Universal Health has an Earnings ESP of -13.39%. This is because its Most Accurate Estimate is pegged at $2.29, lower than the Zacks Consensus Estimate of $2.64. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Universal Health Services, Inc. Price and EPS Surprise
Universal Health Services, Inc. price-eps-surprise | Universal Health Services, Inc. Quote
Zacks Rank: Universal Health carries a Zacks Rank #3, which increases the predictive power of ESP. However, its -13.59% ESP leaves surprise prediction difficult for the stock this time around.
Q4 Highlights and Surprise History
Universal Health’s fourth-quarter 2019 adjusted earnings of $2.79 per share beat the Zacks Consensus Estimate by 6.9%. Moreover, the bottom line increased 17.7% year over year on the back of higher revenues.
The company managed to beat on earnings in two of the trailing four quarters, missing the same in the other two. The average trailing four-quarter positive surprise is 0.01%.
Stocks to Consider
Some stocks worth considering from the medical sector with the perfect mix of elements to surpass estimates in the next releases are as follows:
Centene Corporation (CNC - Free Report) has an Earnings ESP of +21.25% and a Zacks Rank #2. The company is scheduled to release first-quarter earnings on Apr 28.
Anthem, Inc. is slated to announce first-quarter earnings on Apr 29. The stock has an Earnings ESP of +1.28% and a Zacks Rank of 3.
MEDNAX, Inc. (MD - Free Report) is set to report first-quarter earnings on May 7. The stock is #2 Ranked and has an Earnings ESP of +4.15%.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>